The pharma industry has been good to me and my wife.  It has provided a good living and allowed me to grow professionally and personally.  Yet, as an Editor for PM360 and working on a consulting team I have been challenged to either remain quiet when I see clients, focusing too much on things that aren’t important to patients versus listening to our audience at a time when a lot of people are going to need good healthcare.

KEY TAKEAWAY: [inlinetweet prefix=”” tweeter=”” suffix=””]Tech mania is resurgent when it comes to mobile health[/inlinetweet]. Investors are again, glancing at a clock with no hands — and dismissing the risk.  Nobody wants to be left behind in case the next “facebook” of health should appear, but the recent sale of WebMD should be a warning that there is a lot of money to be lost in the mobile health market.